Research Article
Safety and Effectiveness of Mist Antiaris, a Herbal Preparation for Treatment of Peripheral Neuropathy
Table 6
Effect of Mist Antiaris on hematological parameters after four weeks of treatment.
| Parameters | Treatment Group | Control | Mist Antiaris | 10 mg/kg | 100 mg/kg | 200mg/kg |
| WBC (x103 /µL) | 14.9 ± 1.09 | 13.1 ± 1.25 | 14.4 ± 0.77 | 14.2 ± 1.12 | MPV (f L) | 7.20 ± 0.09 | 7.27 ± 0.08 | 7.08 ± 0.07 | 7.26 ± 0.07 | RBC (x106 /µL) | 7.79 ± 0.17 | 8.15 ± 0.08 | 8.14 ±0.20 | 8.20 ± 0.17 | Hb (g/ d L) | 15.0 ± 0.17 | 15.0 ± 0.23 | 15.0 ± 0.32 | 15.3 ± 0.18 | HCT (%) | 47.4 ± 0.63 | 47.8 ± 0.88 | 48.3 ± 1.23 | 49.0 ± 0.60 | MCV (f L) | 60.9 ± 1.04 | 58.7 ± 0.76 | 59.4 ± 0.35 | 59.8 ± 0.84 | MCH (pg.) | 19.3 ± 0.47 | 18.4 ± 0.20 | 18.5 ± 0.13 | 18.7 ± 0.29 | MCHC (g/ d L) | 31.7 ± 0.34 | 31.4 ± 0.15 | 31.1 ± 0.18 | 31.3 ± 0.15 | PLT (x103/ µL) | 875 ± 28.8 | 848 ± 80.8 | 912 ± 27.3 | 899 ± 31.2 | LYM % | 73.8 ± 1.64 | 73.0 ± 2.27 | 73.9 ± 3.26 | 76.8 ± 1.52 | LYM # | 10.9 ± 0.63 | 9.65 ± 0.97 | 10.2 ± 0.42 | 10.9 ± 0.79 | RDW (f L) | 31.4 ± 0.32 | 30.1 ± 0.58 | 30.6 ± 0.41 | 30.8 ± 0.52 |
|
|
Values are Mean ± SEM, n = 6
|